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Background: Ginger leaf (GL) has long been used as a vegetable, tea and herbal medicine. However, its pharmacological
properties are still poorly understood. Thus, we performed in vitro studies to evaluate anti-cancer properties of ginger leaf
and then elucidate the potential mechanisms involved.
Methods: Cell viability was measured by MTT assay. ATF3 expression level was evaluated by Western blot or RT-PCR and
ATF3 transcriptional activity was determined using a dual-luciferase assay kit after the transfection of ATF3 promoter
constructs. In addition, ATF3-dependent apoptosis was evaluated by Western blot after ATF3 knockdown using
ATF3 siRNA.
Results: Exposure of GL to human colorectal cancer cells (HCT116, SW480 and LoVo cells) reduced the cell viability
and induced apoptosis in a dose-dependent manner. In addition, GL reduced cell viability in MCF-7, MDA-MB-231 and
HepG-2 cells. ATF3 knockdown attenuated GL-mediated apoptosis. GL increased activating transcription factor 3 (ATF3)
expressions in both protein and mRNA level and activated ATF3 promoter activity, indicating transcriptional activation
of ATF3 gene by GL. In addition, our data showed that GL-responsible sites might be between -318 and -85 region of
the ATF3 promoter. We also observed that ERK1/2 inhibition by PD98059 attenuated GL-mediated ATF3 expression but
not p38 inhibition by SB203580, indicating ERK1/2 pathway implicated in GL-induced ATF3 activation.
Conclusions: These findings suggest that the reduction of cell viability and apoptosis by GL may be a result of ATF3
promoter activation and subsequent increase of ATF3 expression through ERK1/2 activation in human colorectal
cancer cells.
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Cancer is a major problem of public health in many
other parts of the world including the United States [1].
Among the kinds of cancers, human colorectal cancer is
the third leading cause of cancer-related death in both
male and females in the United States [1]. Although* Correspondence: jjb0403@anu.ac.kr
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unless otherwise stated.surgery and chemotherapy have been the most common
treatment for colorectal cancer, cancer chemoprevention
with dietary factors has received attention as the most ef-
fective approach to reduce colorectal cancer-related mor-
tality. Thus, for the last two decades, many researchers
have tested and reported anti-cancer activities of natural
products in dietary factors such as fruits, vegetables and
teas [2,3].
Gingers as perennial herbs belonging to the family
Zingiberaceae have been widely used as spices, condi-
ments and herbal medicine for treatment of cold, fever,
headache, nausea and digestive problems [4]. Ginger and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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paradols and zingerone exert immuno-modulatory, anti-
apoptotic, anti-tumourigenic, anti-inflammatory, anti-
hyperglycaemic, anti-hyperlipidaemic, antioxidant and
anti-emetic activities [4]. Ginger leaves have also been
used for food flavouring and traditional medicine [5].
Past pharmacological studies of ginger were confined to
rhizomes. Thus, in light of the pharmacological actions
of ginger leaves, this study was performed to investigate
the anti-cancer activity and elucidate the potential
mechanism by which ginger leaves induces the reduc-
tion of cell viability and apoptosis in human colorectal
cancer cells. Here, for the first time, we report that ginger
leaves leads to transcriptional activation of activating tran-
scription factor 3 (ATF3) which may be associated with
the reduction of cell viability and induction of apoptosis in
human colorectal cancer cells.
Methods
Materials
Cell culture media, Dulbecco’s Modified Eagle medium
(DMEM)/F-12 1:1 Modified medium (DMEM/F-12) was
purchased from Lonza (Walkersville, MD, USA). The 3-
(4,5-dimethylthizaol-2-yl)-2,5-diphenyl tetrazolium brom-
ide (MTT) and SP600125 was purchased from Sigma
Aldrich (St. Louis, MO, USA). SB203580 and PD98059
were purchased from Calbiochem (San Diego, CA, USA).
ATF3 antibody and ATF3 siRNA were provided from
Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA).
Antibodies against β-actin and poly (ADP-ribose) poly-
merase (PARP), and control siRNA were purchased from
Cell Signaling (Bervely, MA, USA). ATF3 promoter con-
structs (-1420/+34, -718/+34, -514/+34, -318/+34, -147/+34
and -84/+34) were kindly provided by Dr. S-H Lee
(University of Maryland College Park, MD, USA). All
chemicals were purchased from Fisher Scientific, unless
otherwise specified.
Sample preparation
The leaves of ginger (Zingiber officinale, voucher number:
PARK1003(ANH)) were kindly provided by the Bonghwa
Alpine Medicinal Plant Experiment Station, Korea. One
kilogram of ginger leaf was extracted with 1000 ml of 80%
methanol with shaking for 24 h. After 24 h, the methanol-
soluble fraction was filtered and concentrated to approxi-
mately 20 ml volume using a vacuum evaporator and then
fractionated with petroleum ether and ethyl acetate in a
separating funnel. The ethyl acetate fraction was separated
from the mixture, evaporated by a vacuum evaporator,
and prepared aseptically and kept in a refrigerator.
Cell culture and treatment
Human colorectal cancer cell lines (HCT116, SW480
and LoVo), human breast cancer cell lines (MCF-7 andMDA-MB231) and human hepatocellular carcinoma
(HepG-2) were purchased from Korean Cell Line Bank
(Seoul, Korea) and grown in DMEM/F-12 supplemented
with 10% fatal bovine serum (FBS), 100 U/ml penicillin
and 100 μg/ml streptomycin. The cells were maintained
at 37°C under a humidified atmosphere of 5% CO2. The
extracts of ginger leaf (GL) were dissolved in dimethyl
sulfoxide (DMSO) and treated to cells. DMSO was used
as a vehicle and the final DMSO concentration did not
exceed 0.1% (v/v).
Cell viability
Cell viability was measured using MTT assay system.
Briefly, cells were plated onto 96-well plated and grown
overnight. The cells were treated with 0, 50, 100 and
200 μg/ml of GL for 24 and 48 h. Then, the cells were
incubated with 50 μl of MTT solution (1 mg/ml) for an
additional 2 h. The resulting crystals were dissolved in
DMSO. The formation of formazan was measured by
reading absorbance at a wavelength of 570 nm.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA was prepared using a RNeasy Mini Kit (Qiagen,
Valencia, CA, USA) and total RNA (1 μg) was reverse-
transcribed using a Verso cDNA Kit (Thermo Scientific,
Pittsburgh, PA, USA) according to the manufacturer’s
protocol for cDNA synthesis. PCR was carried out using
PCR Master Mix Kit (Promega, Madison, WI, USA) with
primers for human ATF3 and human GAPDH as follows:
human ATF3: 5′-gtttgaggattttgctaacctgac-3′, and reverse
5′-agctgcaatcttatttctttctcgt-3′; huaman GAPDH: forward
5′-acccagaagactgtggatgg-3′ and reverse 5′-ttctagacggcaggt
caggt-3′.
Transient transfections
Transient transfections were performed using the PolyJet
DNA transfection reagent (SignaGen Laboratories, Ijamsville,
MD, USA) according to the manufacturers’ instruction.
HCT116 and SW480 cells were plated in 12-well plates
at a concentration of 2 × 105 cells/well. After growth
overnight, plasmid mixtures containing 0.5 μg of ATF3
promoter linked to luciferase and 0.05 μg of pRL-null
vector were transfected for 24 h. The transfected cells
were cultured in the absence or presence of GL for the
indicated times. The cells were then harvested in 1 × lu-
ciferase lysis buffer, and luciferase activity was normalized
to the pRL-null luciferase activity using a dual-luciferase
assay kit (Promega, Madison, WI, USA).
Transfection of small interference RNA (siRNA)
The cells were plated in six-well plates and incubated
overnight. HCT116 cells were transfected with control
siRNA and ATF3 siRNA for 48 h at a concentration of
100 nM using TransIT-TKO transfection reagent (Mirus,
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struction. Then the cells were treated with GL (100 μg/ml)
for 24 h.
Cell death assay
Cell death was performed using Cell Death Detection ELI-
SAPLUS Kit (Roche Diagnostics, Indianapolis, IN, USA) ac-
cording to the manufacturer’s instruction. Briefly, HCT116
and SW480 cells were seeded in 12-well plate. After 24 h,
cells were treated with 0, 25, 50 and 100 μM of GL for
24 h. Cytosol was prepared using Nuclear Extract Kit
(Active Motif, Carlsbad, CA, USA). Equal amounts of
cytosolic extracts, immunoreagent containing anti-histone-
biotin, and anti-DNA-POD were added to microplate well
and incubated for 2 h under shaking. After washing, the
ABTS solution was added to each well for 20 min and then
the ABTS stop solution was added. The absorbance was
recorded at 405 nm and 490.
SDS-PAGE and Western blot
After GL treatment, cells were washed with 1 × phos-
phate-buffered saline (PBS), and lysed in radioimmuno-
precipitation assay (RIPA) buffer (Boston Bio Products,
Ashland, MA, USA) supplemented with protease inhibi-
tor cocktail (Sigma-Aldrich, St. Louis, MD. USA) and
phosphatase inhibitor cocktail (Sigma-Aldrich), and cen-
trifuged at 15,000 × g for 10 min at 4°C. Protein concen-
tration was determined by the bicinchoninic acid (BCA)
protein assay (Pierce, Rockford, IL, USA). The proteins
were separated on SDS-PAGE and transferred to PVDF
membrane (Bio-Rad Laboratories, Inc., Hercules, CA,
USA). The membranes were blocked for non-specific
binding with 5% non-fat dry milk in Tris-buffered saline
containing 0.05% Tween 20 (TBS-T) for 1 h at room
temperature and then incubated with specific primary
antibodies in 5% non-fat dry milk at 4°C overnight. After
three washes with TBS-T, the blots were incubated with
horse radish peroxidase (HRP)-conjugated immunoglobu-
lin G (IgG) for 1 h at room temperature and chemilumin-
escence was detected with ECL Western blotting substrate
(Amersham Biosciences, Piscataway, NJ, USA) and visual-
ized in Polaroid film.
Statistical analysis
Statistical analysis was performed with the Student’s un-
paired t-test, with statistical significance set at *, P <0.05.
Results
Effect of GL on cell viability and apoptosis
To investigate whether ginger leaf affects the cell viabil-
ity in human colorectal cancer cells, HCT116, SW480
and LoVo, the cells were incubated with 50, 100 and
200 μg/ml of GL for 24 and 48 h, and cell viability was
measured using MTT assay. As shown in Figure 1A, GLreduced the viability of HCT116 cells by 24 and 59% at
50 μg/ml, 53 and 79% at 100 μg/ml, and 79 and 88% at
200 μg/ml at 24 and 48 h after GL treatment, respect-
ively. We also found that the viability of SW480 cells
was reduced by GL treatment for 24 and 48 h by 23 and
40% at 50 μg/ml, 42 and 57% at 100 μg/ml, and 55 and
76% at 200 μg/ml, respectively (Figure 1B). In addition,
GL suppressed LoVo cell viability by 20 and 33% at
50 μg/ml, 34 and 55% at 100 μg/ml, and 59 and 80% at
200 μg/ml after GL treatment for 24 and 48 h, respect-
ively (Figure 1C). HCT116 and SW480 cells were treated
with 25, 50 and 100 μg/ml of GL for 24 h, and apoptosis
was measured using Western blot against cleaved PARP
and the cell death assay using ELISA-based cell death kit.
As shown in Figure 1D, the cleavage of PARP was observed
at 50 and 100 μg/ml in HCT116 and SW480 cells, respect-
ively, which indicates that GL may induce apoptosis. In
addition, significant increases of cell death were observed in
the cells treated with GL (Figure 1E). To determine if GL
shows a reduction of cell viability in other types of cancer
cells, breast (MCF-7 and MDA-MD-231) and hepatocellu-
lar carcinoma (HepG-2) cells were treated with 100 μg/ml
at 24 h. As a result, GL-treatment for 24 h reduced the cell
viability by 36% in MCF-7, 44% in MDA-MB-231, and 30%
in HepG-2 cells, respectively (Figure 1F). These data indi-
cates that GL may have anti-cancer activity in colorectal
cancer, breast cancer and hepatocellular carcinoma cells.
Effect of GL on ATF3 expression in HCT116 and SW480 cells
Since there is growing evidence that ATF3 is associated
with to cell growth arrest and apoptosis in human colorec-
tal cancer cells [6], we evaluated whether GL affects ATF3
expression in HCT116 and SW480 cells. As shown in
Figure 2A-D, GL-induced ATF3 expressions were observed
at 50 and 100 μg/ml of GL in both protein and mRNA
level. To investigate whether increase in ATF3 expression
by GL treatment was mediated from transcription activa-
tion of ATF3 promoter, ATF3 promoter (-1420/+34) trans-
fected HCT116 and SW480 cells were incubated with 25,
50 and 100 μg/ml of GL for 24 h. As shown in Figure 2E
and F, GL dose-dependently activated ATF3 transcription.
In time-course experiments, we found that the expression
of ATF3 mRNA activation by GL started to be increased
at 1 h after GL treatment in HCT116 cells (Figure 2G).
To see whether ATF3 expression affect GL-mediated
apoptosis, cleaved PARP was measured by Western
blot in ATF3 knock downed-HCT116 cells. As shown in
Figure 2H, knockdown of ATF3 by ATF3 siRNA reduced
the cleavage of PARP by GL, indicating that ATF3 may be
one of important genes in GL-mediated apoptosis.
Kinases affecting GL-induced ATF3 activation
To determine upstream kinase affecting GL-induced
ATF3 transcriptional activation, ATF3 promoter (-1420/+34)
Figure 1 The effects of GL on cell viability and apoptosis in human colorectal cancer cells. HCT116 (A), SW480 (B) and LoVo cells (C) were
treated with 0, 50, 100 and 200 μg/ml of GL for 24 and 48 h. Cell viability was measured using MTT assay system and expressed as % cell viability
compared to the cell without GL treatment. *P < 0.05 compared to cells without GL treatment. (D) HCT116 and SW480 cells were treated with 0,
25, 50 and 100 μg/ml of GL for 24 h. Cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against
PARP. Actin was used as internal control. (E) HCT116 and SW480 cells were treated with 0, 25, 50 or 100 μM of GL for 24 h. the cytosol fraction
was extracted from GL-treated cells, and the cell death was measured using the Cell Death Detection ELISAPLUS Kit, and expressed as absorbance
(A405-A490). *p < 0.05 compared to cells without GL treatment. (F) MCF-7, MDA-MB-231 and HepG-2 cells were treated with 100 μg/ml of GL for
24 h. Cell viability was measured using MTT assay system and expressed as % cell viability compared to the cell without GL treatment. *P < 0.05
compared to cells without GL treatment.
Park et al. BMC Complementary and Alternative Medicine 2014, 14:408 Page 4 of 8
http://www.biomedcentral.com/1472-6882/14/408transfected HCT116 and SW480 cells were pretreated
with 20 μM of PD98059 (ERK1/2 inhibitor) and
SB203580 (p38 inhibitor) for 2 h and co-treated with
100 μg/ml of GL for 24 h. As shown in Figure 3A and B,
ERK1/2 inhibition by PD98059 attenuated GL-mediated
ATF3 promoter activation, while p38 inhibition by SB203580
did not affect ATF3 activation by GL in both HCT116
and SW480 cells. We also investigated whether JNK
signaling affects GL-mediated ATF3 promoter activa-
tion and found that JNK inhibition by SP600125 did not
affect ATF3 promoter activation by GL (data not shown).
We investigated that GL treatment affects ERK1/2 ac-
tivation. As shown in Figure 3C and D, GL enhanced
phosphorylation of ERK1/2 protein. We also tested that
the inhibitions of ERK1/2 by PD98059 and p38MAPK
by SB203580 affect GL-mediated ATF3 protein level. In
these experiments, the inhibition of ERK1/2 by PD98059
ameliorated the increase of ATF3 protein level by GL,
while p38 MAPK inhibition did not affect ATF3 protein
level in HCT116 cells (Figure 3E). Because GL-mediatedATF3 activation was affected by ERK1/2, we evaluated
if ERK1/2 affects GL-mediated apoptosis. As a result,
ERK1/2 inhibition by PD98059 attenuated GL-mediated
cleavage of PARP in HCT116 cells (Figure 3F). These
results indicates that GL-mediated apoptosis may result
from ERK1/2-dependent ATF3 activation.
Identification of ATF3 promoter sites responsible for
GL-induced ATF3 activation
To investigate ATF3 promoter sites which can be respon-
sible for GL-induced ATF3 activation, promoter activity
was measured using different sizes of ATF3 promoter
luciferase constructs (-1420/+34, -718/+34, -514/+34,
-318/+34, -147/+34 and -84/+34). These constructs
were transfected into SW480 cells and treated with
100 μg/ml of GL for 24 h. As shown in Figure 4A, GL
treatment resulted in an increase of promoter activity.
The fold induction in SW480 cells was 5.1, 5.0, 4.4, 4.2,
3.1 and 2.5 in pATF3-1420/+34, pATF3- 718/+ 34,
pATF3- 514/+ 34, pATF3- 318/+ 34, pATF3-147/+ 34,
Figure 2 Effects of GL on ATF3 activation in human colorectal cancer cells. (A, B) HCT116 and SW480 cells were treated with 0, 25, 50 and
100 μg/ml of GL for 24 h. Cell lysates were subjected to SDS-PAGE and the Western blot was performed using antibodies against ATF3. Actin was
used as internal control. For RT-PCR analysis of ATF3 gene expression, total RNA was prepared after GL treatment for 24 h in dose-course experiments
(C, D) or for the indicated times in time-course experiments (G). GAPDH were used as internal control. For ATF3 promoter activity, luciferase construct
containing -1420 to +34 of human ATF3 promoter region was cotransfected with pRL-null vector and the cells were treated with GL for 24 h in
dose-course experiments (E, F) and luciferase activity was measured. *P <0.05 compared to cells without GL treatment. (H) ATF3 siRNA was transfected
into HCT116 for 48 h and then GL was treated for 24 h. Cell lysates were subjected to SDS-PAGE the Western blot was performed using antibodies
against PARP. Actin was used as internal control.
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ATF3 promoter activity more than 4.0-fold in SW480 cells,
GL-responsible sites might be between -318 and -85 region
of the ATF3 promoter. The Fushi tarazu (Ftz) and CREB is
cis-acting elements in ATF3 promoter containing -147
and -85 by program (Gene Regulation, TFSEARCH,
and Transcription Element System). To identify the
role of each cis-acting element, each site-deleted ATF3promoter constructs were transfected into SW480 cells
and treated with 100 μg/ml of GL for 24 h. As shown
in Figure 4B, GL-induced ATF3 promoter activity was
significantly decreased when the CREB site was de-
leted. However, the deletion of Ftz sites did not affect
ATF3 promoter activity by GL. These data indicated
that CREB is an important region in GL-induced ATF3
expression.
Figure 3 Up-stream signaling pathways affecting GL-mediated ATF3 activation. (A, B) Luciferase construct containing -1420 to +34 of
human ATF3 promoter region was cotransfected with pRL-null vector. Then, the cells were pretreated with 20 μM of PD98059 (ERK1/2 inhibitor)
or SB203580 (p38 inhibitor) and then cotreated with 100 μg/ml of GL for 24 h. *P <0.05 compared to cells without the treatment of inhibitors.
(C, D) HCT116 and SW480 cells were treated with 100 μg/ml of GL for indicated times. Cell lysates were subjected to SDS-PAGE and the Western
blot was performed using antibodies against p-ERK1/2 and ERK1/2. Actin was used as internal control. (E) HCT116 cells were pre-treated with
20 μM of PD98059 (ERK1/2 inhibitor) or SB203580 (p38 inhibitor) and then co-treated with 100 μg/ml of EAFAD-B for 6 h. Cell lysates were
subjected to SDS-PAGE the Western blot was performed using antibodies against ATF3. Actin was used as internal control. (F) HCT116 cells were
pretreated with 20 μM of PD98059 (ERK1/2 inhibitor) for 2 h and then co-treated with 100 μM of GL for 24 h. Cell lysates were subjected to
SDS-PAGE the Western blot was performed using antibodies against PARP. Actin was used as internal control.
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Because many dietary factors exert anti-cancer activities,
cancer chomoprevention with dietary factors has re-
ceived attention as the most effective approach to reduce
colorectal cancer-related mortality. Ginger leaves have
been used as the dietary factors such a vegetable and
tea, and the herbal medicine [5]. However, pharmaco-
logical actions of ginger leaves have not been studied.
Here, we evaluated the anti-cancer activity of ginger
leaves and elucidated its potential mechanism. In this
study, we, for the first time, report that ginger leaves
showed an anti-cancer activity associated with ATF3 ac-
tivation in colorectal cancer cells,
ATF3, an ATF/CREB subfamily member, contains the
basic-leucine zipper (b-ZIP) DNA binding domain [7].
ATF3 is dramatically expressed in response to several
stresses in many different tissues and exerts diverse bio-
logical effects [7]. In cancer development, ATF3 exerts
pro-or anti-apoptotic activities dependent on cell or tis-
sue context [8,9]. ATF3 expression was suppressed in
human colorectal cancer [10] and expression of ATF3induced apoptosis, growth arrest of colorectal cancer cells
and Ras-stimulated tumourigenesis [11-13]. On the other
hand, ATF3 induces DNA synthesis and expression of cyc-
lin D1 in hepatocellular carcinoma cells [14] and enhances
cancer cell-initiating features in breast cancer [15]. Al-
though ATF3 has dual effects in cancer development, ATF3
has been regarded as a major target of cancer chemopre-
vention in colorectal cancer. Our data indicate that GL in-
creased ATF3 expression in both protein and mRNA level
in a time- and dose-dependent manner through the activa-
tion of ATF3 promoter. In addition, it was reported that
anti-cancer agents such as indole-3-carbinol [16], conju-
gated linoleic acid [17], epicatechin gallate [18], tolfenamic
acid [19] and PI3 kinase inhibitor [13] induce ATF3-
dependent apoptosis in colorectal cancer cells. In our study,
GL increased the PARP cleavage and reduced the viability
of colorectal cancer cells, indicating that increased apop-
tosis and reduction of cell viability may be mediated by acti-
vation of ATF3 expression in GL-treated cells.
There is a growing body of evidence to suggest that
MAPK signaling is an important pathway regulating ATF3
Figure 4 Identification of ATF3 promoter sites responsible for GL-induced ATF3 activation. (A). Each indicated construct of the ATF3
promoter (0.5 μg) was co-transfected with 0.05 μg of pRL-null vector into SW480 cells, and cells were treated with 100 μg/ml of GL for 24 h.
(B) Each deletion construct (0.5 μg) of the ATF3 promoter was co-transfected with 0.05 μg of pRL-null vector into SW480 cells and cells were
treated with 100 μg/ml of GL for 24 h. Luciferase activity was measured. *P <0.05 compared to cells without GL treatment.
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mediated ATF3 activation is associated with the activation
of ERK1/2, p38 and JNK. ERK1/2 inhibition by PD98059
attenuated GL-induced activation of ATF3 promoter and
ATF3 expression but not in inhibition of p38 and JNK by
SB203580 and bySP600125, indicating that ERK1/2 activa-
tion may contribute to GL-induced ATF3 activation. In
addition, inhibition of ERK1/2 ameliorated GL-mediated
apoptosis. In Western blot analysis for phosphorylation of
ERK1/2, we found that GL induced a prolonged activation
of ERK1/2. Why would late phase ERK activation correlate
with proliferation and apoptosis remains to be under-
stood. However, there is one hypothesis that prolonged ac-
tivation of ERK1/2 can promote accumulation of p21cip1
resulting in cell cycle arrest and apoptosis [21]. Similarly,
several anti-cancer agents have been reported to induce a
prolonged activation of ERK1/2, which results in promot-
ing apoptosis [22-25].
Interestingly, we found that GL-responsible sites for
ATF3 activation might be between -318 and -85 region
of the ATF3 promoter. ATF3 promoter includes various
response elements such as AP-1, ATF/CRE, NF-κB, E2F
and Myc/Max binding sites [26] and especially, EGR-1,
CRE and Ftz are cis-acting elements in ATF3 promoter
(-318/-85) [27] from which our data showed that GL-
induced ATF3 promoter activity was significantly de-
creased when the CREB site was deleted. These data in-
dicated that CREB is an important region in GL-induced
ATF3 expression.
There is a report that ginger leaves has various bioactive
compounds including quercetin, rutin, epicatechin, catechin,kaempferol, naringenin, salicylic acid, cinnamic acid,
flavonoids and phenolics [28]. Among the bioactive
compounds, quercetin has been reported to induce ATF3
expression in human colorectal cancer cells, Caco-2 [29].
Interestingly, we found that ginger leaves had more quer-
cetin (2.124 mg/g dry weight) than ginger rhizoma
(1.105 mg/g dry weight), which is similar to the previous
report [28]. According to the previous study [30,31] quer-
cetin can be efficiently hydrolysed and absorbed in the in-
testinal lumen and plasma. Therefore, it is thought that
quercetin may be responsible for ATF3-mediated apop-
tosis by ginger leaves in human colorectal cancer cells and
quercetin of GL may be absorbed in the intestinal lumen
and plasma of animal.
Conclusions
In conclusion, ginger leaves may induce apoptosis and re-
duction of cell viability, followed by the increased ATF3
expression via activating ATF3 promoter in human colo-
rectal cancer cells. In addition, there is a growing evidence
that ginger leaves had higher antioxidant activity than rhi-
zomes and flowers Eric Chan et al. [5]. Therefore, ginger
leaves has great potential to be developed into functional
foods and other health products.
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